Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CPYPP is an inhibitor of the Rac activators dedicator of cytokinesis 2 (DOCK2; IC50 = 22.8 µM for DOCK2 guanine nucleotide exchange factor (GEF) activity), DOCK5, and DOCK180.1,2 It is selective for these DOCK-A subfamily proteins over the DOCK-D subfamily member DOCK9.1 CPYPP (100 µM) prevents chemokine-induced Rac activation in T and B cells. It also inhibits chemokine-induced migration of T and B cells. CPYPP (5 mg/animal, i.p.) reduces migration of T cells to peripheral lymph nodes in mice following adoptive transfer of spleen cells from knock-in mice expressing GFP-tagged DOCK2. It also reduces myeloperoxidase (MPO) activity in lung tissue, LPS-induced cytokine release in serum, and the severity of lung injury in a mouse model of endotoxemia-induced acute lung injury when administered at a dose of 250 mg/kg.3
WARNING This product is not for human or veterinary use.
1. Blockade of inflammatory responses by a small-
2. Allosteric inhibition of the guanine nucleotide exchange factor DOCK5 by a small molecule. Sci. Rep. 7(1), 14409 (2017).
3. DOCK2 contributes to endotoxemia-